Information for the public Lapatinib or trastuzumab in combination with an aromatase inhibitor for first treatment of metastatic breast cancer that is hormone-receptor and HER2 positive (PDF 191 KB) Published: 27 June 2012 Gwybodaeth i'r cyhoedd (Word 337 KB) Published: 14 September 2012
Lapatinib or trastuzumab in combination with an aromatase inhibitor for first treatment of metastatic breast cancer that is hormone-receptor and HER2 positive (PDF 191 KB) Published: 27 June 2012